Galectin Therapeutics Inc. (GALT)
NASDAQ: GALT · Real-Time Price · USD
2.320
-0.050 (-2.11%)
At close: Apr 28, 2026, 4:00 PM EDT
2.420
+0.100 (4.31%)
After-hours: Apr 28, 2026, 4:47 PM EDT
Galectin Therapeutics Employees
Galectin Therapeutics had 9 employees as of December 31, 2025. The number of employees decreased by 6 or -40.00% compared to the previous year.
Employees
9
Change (1Y)
-6
Growth (1Y)
-40.00%
Revenue / Employee
n/a
Profits / Employee
-$3,441,556
Market Cap
152.72M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| ProQR Therapeutics | 187 |
| Fate Therapeutics | 161 |
| Molecular Partners AG | 134 |
| Alps Group | 93 |
| Agenus | 81 |
| Tenaya Therapeutics | 70 |
| Spero Therapeutics | 25 |
| Tiziana Life Sciences | 9 |
GALT News
- 1 day ago - Galectin Therapeutics, Inc. Investigated by the Portnoy Law Firm - GlobeNewsWire
- 7 weeks ago - Galectin Therapeutics Transcript: KOL event - Transcripts
- 3 months ago - GALT Investors Have Opportunity to Join Galectin Therapeutics Inc. Fraud Investigation with the Schall Law Firm - GlobeNewsWire
- 4 months ago - GALT Investors Have Opportunity to Join Galectin Therapeutics Inc. Fraud Investigation with The Schall Law Firm - Business Wire
- 5 months ago - Galectin Therapeutics Transcript: AGM 2025 - Transcripts
- 5 months ago - Galectin Therapeutics Reports Financial Results for the quarter ended September 30, 2025, and Provides Business Update - GlobeNewsWire
- 6 months ago - Galectin Therapeutics Transcript: H.C. Wainwright Liver Disease Virtual Conference - Transcripts
- 8 months ago - Galectin Therapeutics Transcript: H.C. Wainwright 27th Annual Global Investment Conference - Transcripts